Position in NVS
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$1,003,478
+$25,420 QoQ
Shares Held
6,403
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.94%
of 13F equity value
Holder Rank
#615
of 1,603 holders
Holding Since
Sep 2025
4 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NVS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026SYKON CAPITAL LLC holds $1,340,935 across 2 Drug Manufacturers - General names. NVS ranks #1 (74.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | NVS |
Novartis AG
This page
|
6,403 | $1,003,478 | |
| 2 | PFE |
Pfizer Inc
|
14,014 | $337,457 |
All Filings in NVS
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,003,478 | 6,403 | Shares | Sole | 2026-08-12 | |
| 2026-03-31 | $978,058 | 6,403 | Shares | Sole | 2026-04-22 | |
| 2025-12-31 | $882,781 | 6,403 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $821,120 | 6,403 | Shares | Sole | 2025-11-14 | |
| No filing history on record for this holder in this stock. | ||||||